Paul Schaffer

6.9k total citations · 1 hit paper
199 papers, 5.1k citations indexed

About

Paul Schaffer is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Paul Schaffer has authored 199 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Radiology, Nuclear Medicine and Imaging, 55 papers in Pulmonary and Respiratory Medicine and 52 papers in Oncology. Recurrent topics in Paul Schaffer's work include Radiopharmaceutical Chemistry and Applications (102 papers), Medical Imaging Techniques and Applications (57 papers) and Medical Imaging and Pathology Studies (32 papers). Paul Schaffer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (102 papers), Medical Imaging Techniques and Applications (57 papers) and Medical Imaging and Pathology Studies (32 papers). Paul Schaffer collaborates with scholars based in Canada, France and United States. Paul Schaffer's co-authors include John F. Valliant, C. L. Angell, Hua Yang, François Bénard, Pierre Morel, Valery Radchenko, Andrew K. H. Robertson, Karin A. Stephenson, Thomas J. Ruth and Caterina F. Ramogida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Paul Schaffer

194 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The medicinal chemistry of carboranes

2002 593 citations Paul Schaffer et al. profile →

Peers

Countries citing papers authored by Paul Schaffer

Since Specialization

Citations

This map shows the geographic impact of Paul Schaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Schaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Schaffer more than expected).

Fields of papers citing papers by Paul Schaffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Schaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Schaffer. The network helps show where Paul Schaffer may publish in the future.

Co-authorship network of co-authors of Paul Schaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Schaffer. A scholar is included among the top collaborators of Paul Schaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Schaffer. Paul Schaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Evaluation of²²⁶Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy 2024 ·Journal of Nuclear Medicine ·(unknown), (unknown), (unknown), (unknown), Helen Merkens, Cristina Rodríguez‐Rodríguez, P. Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe, Paul Schaffer	3
2	Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development 2024 ·EJNMMI Physics ·(unknown), (unknown), (unknown), (unknown), Michiel Van de Voorde, Maarten Ooms, Sathiya Sekar, Cristina Rodríguez‐Rodríguez, P. Kunz, Valery Radchenko, Arman Rahmim, Carlos Uribe, Hua Yang, Paul Schaffer	6
3	H₃trica: Versatile Macrocyclic Chelator for [²²⁵Ac]Ac³⁺ and [^155/161Tb]Tb³⁺ Theranostics 2024 ·Inorganic Chemistry ·(unknown), (unknown), Marı́a de Guadalupe Jaraquemada-Peláez, Chris Orvig, Paul Schaffer	2
4	Rearmed Bifunctional Chelating Ligand for ²²⁵Ac/¹⁵⁵Tb Precision-Guided Theranostic Radiopharmaceuticals─H₄noneunpaX 2023 ·Journal of Medicinal Chemistry ·(unknown), Hua Yang, Marı́a de Guadalupe Jaraquemada-Peláez, Helen Merkens, (unknown), (unknown), (unknown), Valery Radchenko, P. Kunz, Paul Schaffer, François Bénard, Chris Orvig	11
5	H₄picoopa─Robust Chelate for ²²⁵Ac/¹¹¹In Theranostics 2022 ·Bioconjugate Chemistry ·(unknown), Marı́a de Guadalupe Jaraquemada-Peláez, Chengcheng Zhang, Jutta Zeisler, Cristina Rodríguez‐Rodríguez, (unknown), Valery Radchenko, Hua Yang, Kuo‐Shyan Lin, François Bénard, Paul Schaffer, Chris Orvig	13
6	Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE 2021 ·EJNMMI Radiopharmacy and Chemistry ·Helge Thisgaard, (unknown), Niels Langkjær, (unknown), (unknown), Mikael Jensen, (unknown), Stefan Zeisler, (unknown), M. C. Cross, Paul Schaffer, Johan Hygum Dam	46
7	[^nat/44Sc(pypa)]⁻: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate 2020 ·Inorganic Chemistry ·(unknown), Marı́a de Guadalupe Jaraquemada-Peláez, Eduardo Aluicio‐Sarduy, Xiaozhu Wang, Dawei Jiang, (unknown), Hsiou‐Ting Kuo, Todd E. Barnhart, Weibo Cai, Valery Radchenko, Paul Schaffer, Kuo‐Shyan Lin, Jonathan W. Engle, François Bénard, Chris Orvig	25
8	²²⁵Ac-H₄py4pa for Targeted Alpha Therapy 2020 ·Bioconjugate Chemistry ·(unknown), Julie Rousseau, Marı́a de Guadalupe Jaraquemada-Peláez, Xiaozhu Wang, Andrew K. H. Robertson, Valery Radchenko, Paul Schaffer, Kuo‐Shyan Lin, François Bénard, Chris Orvig	51
9	Analysis of radioactive waste generated during the cyclotron production of ^99m Tc 2019 ·Physics in Medicine and Biology ·(unknown), Xinchi Hou, (unknown), K. Buckley, François Bénard, Paul Schaffer, A. Ćeller	2
10	A Convenient Synthesis of Difluoroalkyl Ethers from Thionoesters Using Silver(I) Fluoride 2019 ·Chemistry - A European Journal ·(unknown), (unknown), Matthew B. Nodwell, Paul Schaffer, Rainer E. Martin, Robert Britton, Chadron M. Friesen	22
11	Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular ⁸⁹Zr-THPN-Conjugates 2019 ·Inorganic Chemistry ·(unknown), Marı́a de Guadalupe Jaraquemada-Peláez, Julie Rousseau, Helen Merkens, Cristina Rodríguez‐Rodríguez, Chris Orvig, François Bénard, Paul Schaffer, Katayoun Saatchi, Urs O. Häfeli	15
12	Functionally Versatile and Highly Stable Chelator for ¹¹¹In and ¹⁷⁷Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting 2019 ·Bioconjugate Chemistry ·(unknown), Marı́a de Guadalupe Jaraquemada-Peláez, Hsiou‐Ting Kuo, Helen Merkens, Neha Choudhary, (unknown), Una Jermilova, Nadine Colpo, (unknown), Valery Radchenko, Paul Schaffer, Kuo‐Shyan Lin, François Bénard, Chris Orvig	43
13	Electrostatic Effects Accelerate Decatungstate-Catalyzed C–H Fluorination Using [¹⁸F]- and [¹⁹F]NFSI in Small Molecules and Peptide Mimics 2019 ·ACS Catalysis ·Zheliang Yuan, Hua Yang, Noeen Malik, Milena Čolović, David S. Weber, Darryl M. Wilson, François Bénard, Rainer E. Martin, Jeffrey J. Warren, Paul Schaffer, Robert Britton	36
14	Site‐Selective, Late‐Stage C−H ¹⁸F‐Fluorination on Unprotected Peptides for Positron Emission Tomography Imaging 2018 ·Angewandte Chemie ·Zheliang Yuan, Matthew B. Nodwell, Hua Yang, Noeen Malik, Helen Merkens, François Bénard, Rainer E. Martin, Paul Schaffer, Robert Britton	19
15	Site‐Selective, Late‐Stage C−H ¹⁸F‐Fluorination on Unprotected Peptides for Positron Emission Tomography Imaging 2018 ·Angewandte Chemie International Edition ·Zheliang Yuan, Matthew B. Nodwell, Hua Yang, Noeen Malik, Helen Merkens, François Bénard, Rainer E. Martin, Paul Schaffer, Robert Britton	74
16	¹⁸F-Fluorination of Unactivated C–H Bonds in Branched Aliphatic Amino Acids: Direct Synthesis of Oncological Positron Emission Tomography Imaging Agents 2017 ·Journal of the American Chemical Society ·Matthew B. Nodwell, Hua Yang, Milena Čolović, Zheliang Yuan, Helen Merkens, Rainer E. Martin, François Bénard, Paul Schaffer, Robert Britton	113
17	[A decentralized breast cancer screening program in the French department of Bas-Rhin]. 2000 ·PubMed ·Paul Schaffer, B Gairard, (unknown), (unknown), (unknown), (unknown), (unknown)	2
18	[Incidence of colorectal cancer in Bas-Rhin, trend and prediction in 2009]. 2000 ·PubMed ·Daniel Eilstein, Guy Hédelin, Paul Schaffer	8
19	[Opportunistic screening of breast cancer in France]. 1997 ·PubMed ·Suzanne Wait, Paul Schaffer, (unknown), (unknown), (unknown), (unknown)	7
20	[Principles and first results of the European program of breast cancer screening in the Bas-Rhin]. 1991 ·PubMed ·R Rénaud, Paul Schaffer, B Gairard, (unknown), (unknown), (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact